Real-World Experience with Topical 5-Fluorouracil 4% (40 mg/g) Cream for the Treatment of Actinic Keratosis
Dermatology Practical & Conceptual2023Vol. 13(2), pp. e2023151–e2023151
Citations Over TimeTop 15% of 2023 papers
Giulia Briatico, Gabriella Brancaccio, Camila Scharf, Eugenia Veronica Di Brizzi, Sebastiano Pellerone, Stefano Caccavale, Caterina Mariarosaria Giorgio, Enrico Maria Procaccini, Elvira Moscarella, Giuseppe Argenziano
Abstract
In this real-world study 4% 5-FU proved to be highly effective for AK lesions clearance with a favorable safety profile.
Related Papers
- → Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis(2002)168 cited
- → Intensity of Local Skin Reactions During 5-Fluorouracil Treatment Related to the Number of Actinic Keratosis Lesions: A Post Hoc, Exploratory Analysis(2021)21 cited
- → Comparative study of actinic keratosis treatment with 3% diclofenac sodium and 5% 5-fluorouracil(2013)34 cited
- → Topical 5-Fluorouracil associated skin reaction(2017)11 cited
- A comparative study between 5-fluorouracil liposomal 0.5% in cream and 5-fluorouracil 5% in cream in the treatment of actinic keratosis(2014)